Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cohard

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Therapie|July 1, 1994
[Fulminant hepatitis secondary to alprazolam]C H Moulin, A Rolachon, M Cohard, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1993
[Primary sclerosing cholangitis and autoimmune cochlear deafness: a new syndrome?]M Cohard, A Rolachon, D Vetter, et al.
Applied Optics|February 24, 2022
Near ground horizontal high resolution <i>C</i><i>n</i>2 profiling from Shack-Hartmann slopeand scintillation dataC Sauvage, C Robert, L M Mugnier, et al.
Alimentary Pharmacology & Therapeutics|April 1, 2006
Predictors of the placebo response in functional dyspepsiaN J Talley, G R Locke, B D Lahr, et al.
Gastroenterology|December 13, 2000
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study GroupR N Fedorak, A Gangl, C O Elson, et al.
Gut|June 20, 2001
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's diseaseJ F Colombel, P Rutgeerts, H Malchow, et al.
Gut|January 15, 2002
Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gammaH Tilg, C van Montfrans, A van den Ende, et al.
Gastroenterology|December 13, 2000
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study GroupS Schreiber, R N Fedorak, O H Nielsen, et al.
Alcoholism, Clinical and Experimental Research|June 8, 2001
Mechanisms of alcoholic liver disease: cytokinesM G Neuman, D A Brenner, B Rehermann, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Therapie|July 1, 1994
[Fulminant hepatitis secondary to alprazolam]C H Moulin, A Rolachon, M Cohard, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1993
[Primary sclerosing cholangitis and autoimmune cochlear deafness: a new syndrome?]M Cohard, A Rolachon, D Vetter, et al.
Applied Optics|February 24, 2022
Near ground horizontal high resolution <i>C</i><i>n</i>2 profiling from Shack-Hartmann slopeand scintillation dataC Sauvage, C Robert, L M Mugnier, et al.
Alimentary Pharmacology & Therapeutics|April 1, 2006
Predictors of the placebo response in functional dyspepsiaN J Talley, G R Locke, B D Lahr, et al.
Gastroenterology|December 13, 2000
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study GroupR N Fedorak, A Gangl, C O Elson, et al.
Gut|June 20, 2001
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's diseaseJ F Colombel, P Rutgeerts, H Malchow, et al.
Gut|January 15, 2002
Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gammaH Tilg, C van Montfrans, A van den Ende, et al.
Gastroenterology|December 13, 2000
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study GroupS Schreiber, R N Fedorak, O H Nielsen, et al.
Alcoholism, Clinical and Experimental Research|June 8, 2001
Mechanisms of alcoholic liver disease: cytokinesM G Neuman, D A Brenner, B Rehermann, et al.
Pageof 3